CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 69 filers reported holding CTI BIOPHARMA CORP in Q1 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $5,553,000 | +88.2% | 2,239,300 | +123.9% | 4.54% | +89.8% |
Q3 2021 | $2,950,000 | -49.0% | 1,000,000 | -56.8% | 2.39% | -39.7% |
Q2 2021 | $5,786,000 | -20.9% | 2,314,533 | -8.0% | 3.96% | -16.6% |
Q1 2021 | $7,318,000 | -39.4% | 2,514,647 | -32.9% | 4.75% | -36.8% |
Q4 2020 | $12,075,000 | +30.2% | 3,749,890 | -13.1% | 7.53% | -13.9% |
Q3 2020 | $9,274,000 | +1189.8% | 4,313,617 | +596.4% | 8.74% | +1052.0% |
Q2 2020 | $719,000 | +26.8% | 619,460 | +0.4% | 0.76% | +22.4% |
Q1 2020 | $567,000 | +10.3% | 616,695 | +89.4% | 0.62% | +25.0% |
Q4 2019 | $514,000 | +89.0% | 325,610 | +0.1% | 0.50% | +61.6% |
Q3 2019 | $272,000 | -2.5% | 325,185 | +0.2% | 0.31% | -3.2% |
Q2 2019 | $279,000 | -10.9% | 324,452 | +0.4% | 0.32% | +9.3% |
Q1 2019 | $313,000 | +244.0% | 323,026 | +160.6% | 0.29% | +163.6% |
Q4 2018 | $91,000 | -78.7% | 123,941 | -37.2% | 0.11% | -72.2% |
Q3 2018 | $427,000 | – | 197,459 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 8,800,358 | $21,825,000 | 10.02% |
CAXTON CORP | 2,239,300 | $5,553,000 | 4.54% |
Altium Capital Management LP | 2,185,000 | $5,419,000 | 1.49% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,483,829 | $3,680,000 | 1.49% |
Ghost Tree Capital, LLC | 1,200,000 | $2,976,000 | 1.07% |
Lion Point Capital, LP | 1,223,595 | $3,034,000 | 0.81% |
BVF INC/IL | 8,929,690 | $22,146,000 | 0.80% |
NEA Management Company, LLC | 7,140,450 | $17,708,000 | 0.36% |
Knott David M Jr | 221,079 | $548,000 | 0.19% |
Lakeside Advisors, INC. | 97,780 | $242,000 | 0.18% |